chlamydia%20-%20uncomplicated%20anogenital%20infection
CHLAMYDIA - UNCOMPLICATED ANOGENITAL INFECTION

Chlamydia is a gram negative obligate intracellular bacteria that causes sexually-transmitted infection.

Chlamydia trachomatis is the primary cause of pelvic inflammatory disease (PID) in women which may lead to ectopic pregnancy, infertility, or chronic pelvic pain.
Most infected females are asymptomatic.
But some females may experience vaginal discharge, dysuria, lower abdominal pain, abnormal vaginal bleeding (postcoital or intermenstrual) or breakthrough bleeding, dyspareunia, conjunctivitis, proctitis and reactive arthritis.

Chlamydia%20-%20uncomplicated%20anogenital%20infection Management

Follow Up

  • Patients treated with recommended or alternative regimens do not need to be re-tested for Chlamydia after completing treatment unless symptoms persist or re-infection is suspected or adherence to treatment is in question
  • Test of cure 3-4 weeks after completing therapy is recommended in pregnant patients
    • Culture is the only test used to evaluate efficacy of treatment
    • NAAT done <3 weeks after treatment is completed may yield false-positive results due to the presence of dead organisms 
  • Test for cure may be considered after 3 weeks in those treated with Erythromycin
  • A follow-up face-to-face or phone interview within 4 weeks of treatment is advisable
  • Most post-treatment infections result from reinfection
  • Test for re-infection is advised 3 months after treatment completion or within the following 3-12 months

Counselling

HIV/STI Counseling and Testing

  • STI consultation allows for an opportunity to discuss patient’s risk factors for STIs and HIV
  • Determine patient’s risk for HIV and discuss HIV testing
  • Testing for HIV is recommended and should be offered to all persons seeking evaluation and treatment for STIs
    • Pretest and post-test counseling as well as informed consent are part of the testing procedure
    • Concomitant infection with HIV may complicate management and control of some STIs 
  • Patient diagnosed with Chlamydia should be encouraged to undergo screening against other STIs apart from HIV (eg hepatitis B, syphilis)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.